Advertisement

Topics

ATCC and BioAgilytix Announce Partnership to Support Biopharmaceutical R&D

10:26 EDT 19 Oct 2016 | PharmPro

ATCC and BioAgilytix have announced a strategic partnership to develop new and custom cell-based assays to accelerate and enhance biopharmaceutical research and development.
Contributed Author: 
ATCC and BioAgilytix

Original Article: ATCC and BioAgilytix Announce Partnership to Support Biopharmaceutical R&D

NEXT ARTICLE

More From BioPortfolio on "ATCC and BioAgilytix Announce Partnership to Support Biopharmaceutical R&D"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...